This section is dedicated to recommendations on special testing and/or modification of blood components and their utilization, including the use of irradiated components and CMV seronegative components. Special testing of donors / recipients, such as RhD genotyping of prenatal patients, is also included.
Copy citation
Prokopchuk-Gauk O, Robitaille N, Tinmouth A, Shih A, Musuka C, Devine D, et al. Recommendations for use of Irradiated Blood Components in Canada: A NAC and CCNMT Collaborative Initiative [Internet]. Ottawa: National Advisory Committee on Blood and Blood Products; October 17, 2017 [updated 2023 10 16; cited YYYY MM DD]. Available from: https://nacblood.ca/en/resource/recommendations-use-irradiated-blood-components-canada